| Desitin Pharma GmbH - Apydan extent 150 mg, Tabletten |
| 57883 | | 01 | | Apydan extent 150 mg | | Tabletten | | N03AF02 | | Oxcarbazepin | | 10.11.2010 | | |
|
| Composition |
| oxcarbazepinum 150 mg, ammonio methacrylatis copolymerum B, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.08 mg, magnesii stearas, E 101 pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Oxcarbazepine | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Oxcarbazepine | 150 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Ammonio Methacrylatis Copolymerum B | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 101 | | color. | | Magnesii Stearas | | | | Pro Compresso | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 50 Comprimé(s) | 7.02 | 16.85 | B | LS | Oui |
|
